D. LYNN LORIAUX, M.D., Ph.D.; RAYMOND MENARD, Ph.D.; ADDISON TAYLOR, M.D., Ph.D.; JULIO C. PITA, M.D.; RICHARD SANTEN, M.D.
Therapy with spironolactone is often associated with estrogenlike side-effects, including impotence and gynecomastia in men and menstrual irregularity in women. Several possible mechanisms by which spironolactone could cause these side-effects have been identified. Spironolactone has been shown to affect both gonadal and adrenal steroidogenesis, to elevate plasma gonadotrophin levels in children, and to act as an antiandrogen at the target tissue level. This conference presents a discussion of how these effects might interact to produce the endocrine side effects associated with spironolactone therapy.
Learn more about subscription options.
Register Now for a free account.
LORIAUX DL, MENARD R, TAYLOR A, PITA JC, SANTEN R. Spironolactone and Endocrine Dysfunction. Ann Intern Med. 1976;85:630–636. doi: 10.7326/0003-4819-85-5-630
Download citation file:
Published: Ann Intern Med. 1976;85(5):630-636.
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only